SUBSCRIBE
SUBSCRIBE

GSK

NEWS
Biotech Bay
Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B
Dynavax announced it has secured a $175 million non-dilutive term loan agreement to commercialize Heplisav-B.
February 20, 2018
 · 
2 min read
 · 
Alex Keown
Why Novavax Could be a Millionaire-Maker Stock
BioCapital
Why Novavax Could be a Millionaire-Maker Stock
If you had a crystal ball, you probably would have invested in Berkshire Hathaway in 1964, or Apple in the 1980s.
February 16, 2018
 · 
3 min read
 · 
Mark Terry
Drug Development
GlaxoSmithKline’s Booming Pipeline Under CEO Emma Walmsley
Since Emma Walmsley took over leadership at Glaxo, expectations have been both high and hypercritical.
February 7, 2018
 · 
3 min read
 · 
Mark Terry
Policy
Another Day, Another Breakthrough Tag for GlaxoSmithKline’s Bexsero
Bexsero is the first vaccine in the world to receive the designation twice.
February 7, 2018
 · 
2 min read
 · 
Alex Keown
5 Tasty Takeover Targets for 2018
Deals
GSK, Reckitt are the Only Suitors for Pfizer’s $20B Consumer Health Biz
Companies including Sanofi, J&J, Nestle have dropped out.
February 5, 2018
 · 
1 min read
Trevena Slashes 30% of R&D Jobs Amid Cost Cuts
Business
Sanofi Becomes the Latest Drugmaker to Feel the Heat From the Shrinking Diabetes Market
Sanofi has announced major restructuring, which will involve about 400 job cuts in the U.S.
January 26, 2018
 · 
1 min read
Deals
J&J Bows Out of Race for Pfizer’s $20B Consumer Health Biz
Now insiders say J&J has decided it is no longer interested.
January 26, 2018
 · 
2 min read
 · 
Mark Terry
What Brent Saunders Thinks About a Possible Allerg
Deals
Rumor Alert: Allergan in Talks to Buy Out KaNDy Therapeutics in $400M Deal
KaNDy Therapeutics is a clinical-stage company that is focused on female sex-hormone related conditions.
January 25, 2018
 · 
2 min read
 · 
Mark Terry
Business
Novartis Poised for Growth as CEO Hands Baton to Successor
Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires.
January 24, 2018
 · 
3 min read
 · 
Alex Keown
Load More
  • 2026 - Best Places to Work - Badge (1).png
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Samsung Biologics completes acquisition of GSK’s manufacturing facility in Rockville, Maryland
April 1, 2026
 · 
3 min read
Press Releases
GSK’s RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk
March 15, 2026
 · 
9 min read
Press Releases
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen
February 26, 2026
 · 
4 min read
Press Releases
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing
February 26, 2026
 · 
6 min read
Press Releases
35Pharma to be Acquired by GSK to Accelerate Development of HS235, a Potential Best-in-Class Investigational Medicine for Pulmonary Hypertension (PH)
February 25, 2026
 · 
5 min read
Press Releases
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
February 24, 2026
 · 
3 min read
Press Releases
BioVersys and Partners’ Phase 2a Tuberculosis Trial Results Published in New England Journal of Medicine
February 19, 2026
 · 
9 min read
Press Releases
ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM
February 18, 2026
 · 
8 min read
Press Releases
GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows
February 18, 2026
 · 
15 min read
Press Releases
JAX-NYSCF Collaborative and GSK Announce Collaboration to Advance Translational Models for Neurodegenerative Disease Research
February 17, 2026
 · 
3 min read
Load More